10.01.18
Exsymol, which was founded in 1972, has grown from a small staff of four to a company that employs nearly 50, some 25% of which are researchers (cell and molecular biology, biotechnology, fine chemistry). This active ingredients company is addressing interest in customized beauty solutions.
“We have different strategies to accompany these brands in their project,” said Christophe Paillet, director of communication and customer care.
According to company, there are practical aspects that make offering customized formulations more difficult, such as regulatory and toxicological issues due to the number of possible formulae. Every possible combination should be evaluated for safety and toxicity, he noted.
When working with brands that rely on “skin genetic finger printing,” Exsymol suggests to its customers the appropriate active ingredients to maintain them from a preventive point of view. In that respect, Exsymol identified a list of genes (e.g. MMP1, NQO1, TNF-alpha and FLG) related to specific skin functions (e.g. collagen production, photoaging, inflammation and atopic dermatitis) for which we propose the appropriate active ingredient.
“If a preliminary gene study reveals a particular sensitivity to TNF-alpha, therefore inflammation, we would suggest to select among our active ingredients for which we have evidenced an action on TNF-alpha,” he said.
More info: www.exsymol.com
“We have different strategies to accompany these brands in their project,” said Christophe Paillet, director of communication and customer care.
According to company, there are practical aspects that make offering customized formulations more difficult, such as regulatory and toxicological issues due to the number of possible formulae. Every possible combination should be evaluated for safety and toxicity, he noted.
When working with brands that rely on “skin genetic finger printing,” Exsymol suggests to its customers the appropriate active ingredients to maintain them from a preventive point of view. In that respect, Exsymol identified a list of genes (e.g. MMP1, NQO1, TNF-alpha and FLG) related to specific skin functions (e.g. collagen production, photoaging, inflammation and atopic dermatitis) for which we propose the appropriate active ingredient.
“If a preliminary gene study reveals a particular sensitivity to TNF-alpha, therefore inflammation, we would suggest to select among our active ingredients for which we have evidenced an action on TNF-alpha,” he said.
More info: www.exsymol.com
